Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) EBITDA Margin (QoQ) (2009 - 2026)

Analysis

Bio-Rad Laboratories (BIO) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 539.00
Mar 31, 2026 2,291.00
Dec 31, 2025 -2,715.00
Sep 30, 2025 -183.00
Jun 30, 2025 778.00
Mar 31, 2025 -469.00
Dec 31, 2024 -119.00
Sep 30, 2024 -597.00
Jun 30, 2024 859.00
Mar 31, 2024 -669.00
Dec 31, 2023 -40.00
Sep 30, 2023 123.00
Jun 30, 2023 401.00
Mar 31, 2023 -710.00
Dec 31, 2022 235.00
Sep 30, 2022 -388.00
Jun 30, 2022 -313.00
Mar 31, 2022 483.00
Dec 31, 2021 -490.00
Sep 30, 2021 356.00